Homegrown antibody biosimilar products are accelerating their penetration into the global market, as two makers -- Samsung Bioepis and Celltrion – have scored 11 approvals in Europe and eight in the U.S.The achievement came eight years after Celltrion won the nod for Remsima (ingredient: infliximab)
Korea's daily Covid-19 tally reached an all-time high on Friday, due mainly to the mass migrations during the Chuseok holiday last week.The Korea Disease Control and Prevention Agency (KDCA) confirmed 2,434 new virus cases, including 2,416 local infections, breaking the previous record of 2,221 on A
Huons has signed an agreement with AriBio, a biotech firm specializing in medicines for neurodegenerative and infectious disease, to develop new brain disease and dementia drugs targeting the global market.The two partners signed an agreement to develop AriBio's treatment candidates for brain diseas
Ildong Group is speeding up preparations to list its affiliate Ildong Bioscience on the stock market.The group said it decided to sell some of its stake in Ildong Bioscience within the limit that does not affect management rights. The move is part of preparations for an initial public offering of Il
The mental health of young women and children has shown the most dangerous signs of all demographic groups since the outbreak of Covid-19 some one-and-a-half years ago, a lawmaker said Friday.The number of women in their 20s and 30s treated for depression and stress has continued to rise throughout
EuBiologics, a Korean Covid-19 vaccine developer, is expected to license out a vaccine adjuvant technology to a U.S. biopharmaceutical company, industry sources said.The vaccine adjuvant market used to be dominated by multinational pharmaceutical companies, but industry officials pay attention to wh
Medibloc said it has launched Dr. Palette, a next-generation cloud-based electronic medical record (EMR) service."Dr. Palette is a product that maximizes user convenience through mobile EMR linked to web EMR web, complete linkage with industrial complex servers, and automatic update of notices and f
Researchers at Seoul National University Hospital (SNUH) have developed a peptide to promote hair growth and suppress hair loss symptoms.Hair loss is a painful condition that affects millions of people worldwide and has various causes such as aging, hormonal disorders, and side effects of various dr
Yuhan Corp.’s new anti-cancer drug Leclaza (ingredient: lazertinib), in combination with Janssen’s Rybrevant (ingredient: amivantamab), raised the response rate and extended the duration of response in advanced non-small cell lung cancer (NSCLC) patients who failed previous treatment.Researchers pre
Cytiva, a U.S. company supplying raw and subsidiary materials for vaccine production, decided to invest $52.5 million in Korea until 2024 to build manufacturing facilities for global capacity expansion.Vaccine developers and research institutes from Korea and the U.S. also agreed to cooperate in dev
Despite the prolonging Covid-19 pandemic, many Korean biopharmaceutical companies took part in the 2021 European Society for Medical Oncology (ESMO) Congress, one of the largest cancer meetings globally, to present their development of pipelines.ESMO presents the latest scientific developments in ba
The health authorities predicted on Thursday that Covid-19 cases might resurge down the road as the impact of a massive population movement during the Chuseok holiday might appear from next week.The Korea Disease Control and Prevention Agency (KDCA) confirmed 1,716 new virus cases, including 1,698 l
Samsung Biologics said Wednesday that it has launched S-Cellerate, a pharmaceutical consignment development organization (CDO) platform that shortens the period for developing drugs, at the 2021 BioProcess International Conference.According to the company, S-Cellerate significantly shortens the time
Access Bio signed an agreement with PharmGen Science and New Jersey’s IVY Pharma to jointly develop a biosimilar of Covid-19 mRNA vaccine as part of the global vaccine partnership between Korea and the U.S.Under the accord, Access Bio and PharmGen Science will co-invest in IVY Pharma’s research on c
Cosmetic injections, such as facial contouring shots and salmon injections, lacked evidence to prove efficacy, a state agency said.On Thursday, the National Evidence-based Healthcare Collaborating Agency (NECA) released the results of its study on the safety and efficacy of injections used for cosme
Celltrion said Thursday that it would supply DiaTrust COVID-19 antigen rapid test to Defense Logistics Agency, a combat support agency in the U.S. Department of Defense (DoD), through its subsidiary Celltrion USA.Under the accord, Celltrion USA will start supplying the antigen rapid diagnostic kit t
Sanofi-Aventis Korea said Thursday that oral biologic Dupixent (ingredient: dupilumab) has reaffirmed its efficacy in improving the quality of life of severe asthma patients by preventing symptom exacerbations.The company presented its study results at a recent online meeting hosted by the European
Korea and the U.S. will strengthen vaccine partnerships in the private sector to overcome the global health crisis driven by the Covid-19 pandemic, Cheong Wa Dae said Tuesday.On Tuesday morning in New York, vaccine companies and research institutes from the two countries held a signing ceremony to e
After getting the nod in Europe, Samsung Bioepis has gained U.S. marketing approval for a biosimilar referencing Lucentis to enter the 4 trillion won ($3.38 billion) worth global age-related macular degeneration (AMD) market.Samsung Bioepis recently signed a license agreement with Genentech, the dev
The government has recently authorized Covid-19 therapy Regkirona, developed by Celltrion, more than a year-and-a-half after the nation recorded the first confirmed case in early 2020.Now the challenge for most drugmakers here is more convenient oral therapy.The Ministry of Food and Drug Safety rece